Anthony Chang
Diagnostic Pathology: Transplant Pathology
Anthony Chang
Diagnostic Pathology: Transplant Pathology
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This volume in the Diagnostic Pathology series is an ideal point-of-care resource for practitioners at all levels of experience and training. Covering the full range of solid organ transplantation (SOT) of the kidney, liver, heart, lung, pancreas, intestine, and more, it provides a current understanding of transplant immunology and pathology to help ensure accurate diagnosis for optimal clinical management. Richly illustrated and easy to use, Diagnostic Pathology: Transplant Pathology, third edition, is a visually stunning, one-stop reference for practicing pathologists, transplant…mehr
Andere Kunden interessierten sich auch für
- Laura W LampsDiagnostic Pathology: Hepatobiliary and Pancreas309,99 €
- Vania NoséDiagnostic Pathology: Familial Cancer Syndromes377,99 €
- Diagnostic Pathology: Gastrointestinal166,99 €
- Romil SaxenaPractical Hepatic Pathology: A Diagnostic Approach363,99 €
- Rhonda K. YantissGastrointestinal Pathology: Common Questions and Diagnostic Dilemmas, an Issue of Surgical Pathology Clinics84,99 €
- Robert SoslowCurrent Concepts in Gynecologic Pathology: Epithelial Tumors of the Gynecologic Tract, an Issue of Surgical Pathology Clinics74,99 €
- David SchifferBrain Tumor Pathology: Current Diagnostic Hotspots and Pitfalls191,99 €
-
-
-
This volume in the Diagnostic Pathology series is an ideal point-of-care resource for practitioners at all levels of experience and training. Covering the full range of solid organ transplantation (SOT) of the kidney, liver, heart, lung, pancreas, intestine, and more, it provides a current understanding of transplant immunology and pathology to help ensure accurate diagnosis for optimal clinical management. Richly illustrated and easy to use, Diagnostic Pathology: Transplant Pathology, third edition, is a visually stunning, one-stop reference for practicing pathologists, transplant practitioners, and students of organ transplantation. * Covers all areas of transplant pathology, incorporating the collective knowledge and experience from a team of transplant pathology experts with the latest updates from the 2022 Banff classification * Groups content by specific organ transplant, including kidney, liver, heart, lung, intestine, pancreas, and vascularized composite allotransplantation * Features sweeping updates throughout, including new chapters on transplant immunology that cover chronic viral infections and the immune response, immune manipulation and accommodation, and graft-vs.-host disease * Contains a new chapter on islet cell transplantation and new, detailed information on xenotransplantation-specifically kidney xenograft * Covers advances in vascularized composite allografts (hands, face, uterus, phallus) transplantation * Features more than 1,500 superb images, including histology, gross pathology, full-color illustrations, and radiologic images * Employs consistently templated chapters, bulleted content, key facts, annotated images, and an extensive index for quick, expert reference at the point of care * Includes an eBook version that enables you to access all text, figures, and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Any additional digital ancillary content may publish up to 6 weeks following the publication date
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Elsevier Health Sciences
- 3rd edition
- Seitenzahl: 616
- Erscheinungstermin: 22. Mai 2024
- Englisch
- Abmessung: 284mm x 224mm x 32mm
- Gewicht: 1928g
- ISBN-13: 9780443250088
- ISBN-10: 0443250081
- Artikelnr.: 69734761
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: Elsevier Health Sciences
- 3rd edition
- Seitenzahl: 616
- Erscheinungstermin: 22. Mai 2024
- Englisch
- Abmessung: 284mm x 224mm x 32mm
- Gewicht: 1928g
- ISBN-13: 9780443250088
- ISBN-10: 0443250081
- Artikelnr.: 69734761
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
Anthony Chang, MD, is a Professor, Department of Pathology, University of Chicago with a specialty in renal pathology. His research interests include the role of B and plasma cells in lupus nephritis and transplant rejection. He is past president of the Renal Pathology Society (2017) and Chicago Pathology Society (2011-2013). He has taught more than 30 educational courses at the annual meetings for the American Society Clinical Pathology, College of American Pathologists, US & Canadian Academy of Pathology, American Society of Nephrology, American College of Rheumatology, and American Urological Association.
SECTION 1: IMMUNOLOGY 4 Immune Response in Organ Transplantation Roshini Sarah Abraham
PhD 8 Regulatory Immune Cells and Transplant Tolerance Roshini Sarah Abraham
PhD 14 Viral Infections and Immune Response Sanya J. Thomas
MD and Roshini Sarah Abraham
PhD 20 Genetics of Complement Variants in Atypical HUS and TMA Roshini Sarah Abraham
PhD 24 Laboratory-Based Immune Monitoring in Organ Transplantation Sanya J. Thomas
MD and Roshini Sarah Abraham
PhD 30 Introduction to Xenotransplantation Roshini Sarah Abraham
PhD 32 Graft-vs.-Host Disease in Solid Organ Transplantation Sanya J. Thomas
MD and Roshini Sarah Abraham
PhD SECTION2: HLA TESTING 36 Human Leukocyte Antigen System Manish J. Gandhi
MD 38 Histocompatibility Testing Manish J. Gandhi
MD 40 Transplantation and HLA Manish J. Gandhi
MD 44 ABO Blood Group Antigens and Transplantation Manish J. Gandhi
MD 46 Apheresis and Transplantation Manish J. Gandhi
MD 48 HLA and Transfusion Manish J. Gandhi
MD SECTION 3: IMMUNOSUPPRESSIVE DRUGS 52 Mechanism of Action of Immunosuppressive Drugs Loralie Langman
PhD and Florian Lemaitre
PharmD
PhD 54 Therapeutic Drug Monitoring in Transplant Patients Loralie Langman
PhD and Florian Lemaitre
PharmD
PhD 58 History of Immunosuppression Drugs in Transplantation Loralie Langman
PhD and Florian Lemaitre
PharmD
PhD SECTION 4: KIDNEY TRANSPLANTATION 62 History of Kidney Transplantation Lynn D. Cornell
MD 64 Pathologic Classification of Renal Allograft Diseases Robert B. Colvin
MD 66 Examination of End-Stage Kidney Shane Meehan
MB
BCh 72 Evaluation of End-Stage Kidney Shane Meehan
MB
BCh 78 Evaluation of Allograft Kidney Lynn D. Cornell
MD and Evan Farkash
MD
PhD 84 Evaluation of Donor Kidney Lynn D. Cornell
MD and Evan Farkash
MD
PhD 90 Evaluation of Transplant Nephrectomy Shane Meehan
MB
BCh and Evan Farkash
MD
PhD 94 Evaluation of Fibrosis A. Brad Farris
III
MD
MBA 98 Protocol Biopsies Lynn D. Cornell
MD and Evan Farkash
MD
PhD 102 Accommodation Lynn D. Cornell
MD 104 Tolerance Robert B. Colvin
MD SURGICAL COMPLICATIONS 108 Acute Allograft Ischemia A. Brad Farris
III
MD
MBA 112 Size Mismatch Allograft Injury Anthony Chang
MD and Yael K. Heher
MD
MPH 114 Urine Leak A. Brad Farris
III
MD
MBA 115 Lymphocele A. Brad Farris
III
MD
MBA 116 Multinucleated Endotheliopathy Jonathan Zuckerman
MD
PhD 120 Transplant Renal Artery Stenosis A. Brad Farris
III
MD
MBA 122 Transplant Renal Artery or Vein Thrombosis A. Brad Farris
III
MD
MBA 124 Kidney Xenografts Ivy A. Rosales
MD ALLOGRAFT REJECTION 128 Hyperacute Rejection Lynn D. Cornell
MD and Michael Mengel
MD 132 Acute T-Cell-Mediated Rejection Lynn D. Cornell
MD and Michael Mengel
MD 142 Chronic T-Cell-Mediated Rejection Lynn D. Cornell
MD and Michael Mengel
MD 146 Acute Antibody-Mediated Rejection Lynn D. Cornell
MD and Michael Mengel
MD 154 Chronic Antibody-Mediated Rejection Lynn D. Cornell
MD and Michael Mengel
MD 166 Transcript Analysis of Renal Transplant Biopsies Michael Mengel
MD and R. Neal Smith
MD
PhD RECURRENT AND DE NOVO DISEASES 170 Diseases That Recur in Allografts Anthony Chang
MD
Lynn D. Cornell
MD
and R. Neal Smith
MD
PhD 176 De Novo Focal Segmental Glomerulosclerosis Anthony Chang
MD and Astrid Weins
MD
PhD 178 De Novo Membranous Nephropathy Anthony Chang
MD 182 Anti-GBM Disease in Alport Syndrome Anthony Chang
MD and R. Neal Smith
MD
PhD 184 Chimerism Transition Syndrome A. Brad Farris
III
MD
MBA 186 Late Posttransplant Histology Lynn D. Cornell
MD KIDNEY PATHOLOGY OF RECIPIENTS OF OTHER TRANSPLANTS 188 Kidney Diseases in Nonrenal Transplant Recipients Robert B. Colvin
MD 192 Graft-vs.-Host Glomerulopathies Anthony Chang
MD and Yael K. Heher
MD
MPH DRUG TOXICITIES 194 Calcineurin Inhibitor Toxicity Shane Meehan
MB
BCh 200 mTOR Inhibitor Toxicity Lynn D. Cornell
MD INFECTIONS 202 Acute Pyelonephritis Neeraja Kambham
MD 210 Polyomavirus Nephritis Anthony Chang
MD and Evan Farkash
MD
PhD 218 Adenovirus Infection Anthony Chang
MD and R. Neal Smith
MD
PhD 220 Cytomegalovirus Infection Anthony Chang
MD and R. Neal Smith
MD
PhD 222 Mucormycosis Anthony Chang
MD 224 Histoplasmosis Anthony Chang
MD 225 Candidiasis Anthony Chang
MD 226 Cryptococcosis Anthony Chang
MD 227 Aspergillosis Anthony Chang
MD 228 Coccidioidomycosis Anthony Chang
MD 229 Paracoccidioidomycosis Anthony Chang
MD 230 Microsporidiosis Robert B. Colvin
MD 232 Tuberculosis Neeraja Kambham
MD 234 Malakoplakia Neeraja Kambham
MD 238 Nocardiosis Neeraja Kambham
MD SECTION 5: LIVER TRANSPLANTATION 242 Pathologic Classification of Liver Allograft Diseases Lindsay Alpert
MD and John Hart
MD 244 Gross Evaluation of Native Liver Lindsay Alpert
MD and John Hart
MD 248 Evaluation of Failed Liver Allograft Lindsay Alpert
MD and John Hart
MD 250 Evaluation of Donor Liver John Hart
MD 254 History of Liver Transplantation Anthony Chang
MD and John Hart
MD POSTTRANSPLANT SURGICAL COMPLICATIONS 256 Preservation Injury Hanlin L. Wang
MD
PhD 258 Hepatic Artery Thrombosis Lisa Yerian
MD and John Hart
MD 260 Portal Vein Thrombosis Lisa Yerian
MD and John Hart
MD 262 Bile Duct Stricture
Leak
Sludge
Biloma Hanlin L. Wang
MD
PhD 264 Hepatic Venous Outflow Obstruction Hanlin L. Wang
MD
PhD 268 Small-for-Size (Hyperperfusion) Syndrome Hanlin L. Wang
MD
PhD ALLOGRAFT REJECTION 270 T-Cell-Mediated Rejection
Liver Lisa Yerian
MD and John Hart
MD 274 Antibody-Mediated Rejection
Liver Hanlin L. Wang
MD
PhD
Robert B. Colvin
MD
and Richard Masia
MD
PhD 278 Chronic (Ductopenic) Rejection Matthew M. Yeh
MD
PhD and John Hart
MD RECURRENT DISEASES IN LIVER ALLOGRAFT 280 Recurrent Hepatitis B Virus Lindsay Alpert
MD and John Hart
MD 282 Recurrent Hepatitis C Virus Lindsay Alpert
MD and John Hart
MD 286 Fibrosing Cholestatic HBV or HCV Hepatitis Lindsay Alpert
MD and John Hart
MD 288 Recurrent Autoimmune Hepatitis Lindsay Alpert
MD and John Hart
MD 290 Recurrent Primary Biliary Cholangitis Lindsay Alpert
MD and John Hart
MD 292 Recurrent Primary Sclerosing Cholangitis Lindsay Alpert
MD and John Hart
MD 294 Recurrent Fatty Liver Disease Lindsay Alpert
MD and John Hart
MD INFECTIONS 296 Cytomegalovirus Maria Westerhoff
MD and Lei Zhao
MD
PhD 298 Herpes Simplex Virus Maria Westerhoff
MD and Lei Zhao
MD
PhD 300 Adenovirus
Liver Maria Westerhoff
MD and Lei Zhao
MD
PhD 302 Hepatitis E Virus Maria Westerhoff
MD and Lei Zhao
MD
PhD 304 Epstein-Barr Virus
Liver Maria Westerhoff
MD and Lei Zhao
MD
PhD 308 Fungal Infections
Liver Maria Westerhoff
MD and Lei Zhao
MD
PhD LATE-GRAFT DYSFUNCTION 310 Plasma Cell-Rich Rejection Lisa Yerian
MD and John Hart
MD 312 Graft-vs.-Host Disease
Liver Lisa Yerian
MD and John Hart
MD SECTION 6: HEART TRANSPLANTATION 316 Pathologic Classification of Cardiac Allograft Diseases Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 318 Evaluation of Failed Native and Transplanted Heart Aliya N. Husain
MD and Phillip D. McMullen
MD
PhD 320 History of Heart Transplantation Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD EVALUATION OF EXPLANTED HEART 322 Ischemic Heart Disease Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 326 Dilated Cardiomyopathy Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 330 Hypertrophic Cardiomyopathy Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 334 Congenital Heart Disease Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 338 Sarcoidosis
Heart Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 340 Arrhythmogenic Cardiomyopathy Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 344 Other Causes of End-Stage Heart Disease Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD ALLOGRAFT REJECTION 350 Acute Cellular Rejection
Heart Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 354 Antibody-Mediated Rejection
Heart Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 356 Chronic Allograft Vasculopathy
Heart Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD NONINFECTIOUS LESIONS 358 Quilty Lesions Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 360 Site of Previous Biopsy Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD INFECTIONS 362 Myocarditis Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD SECTION 7: LUNG TRANSPLANTATION 370 Pathologic Classification of Lung Allograft Diseases Jefree J. Schulte
MD and Aliya N. Husain
MD 372 Examination of Native and Transplanted Lungs Jefree J. Schulte
MD and Aliya N. Husain
MD 374 History of Lung Transplantation Jefree J. Schulte
MD and Aliya N. Husain
MD EVALUATION OF FAILED NATIVE LUNG 376 Emphysema Jefree J. Schulte
MD and Aliya N. Husain
MD 378 Cystic Fibrosis Jefree J. Schulte
MD and Aliya N. Husain
MD 380 Idiopathic Pulmonary Fibrosis Jefree J. Schulte
MD and Aliya N. Husain
MD 382 Connective Tissue Disease-Associated Interstitial Lung Disease Jefree J. Schulte
MD and Aliya N. Husain
MD 384 Sarcoidosis
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD 386 Pulmonary Arterial Hypertension Jefree J. Schulte
MD and Aliya N. Husain
MD 388 Other Causes of End-Stage Lung Disease Jefree J. Schulte
MD and Aliya N. Husain
MD SURGICAL COMPLICATIONS 392 Surgical Aspects and Complications
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD ALLOGRAFT REJECTION 394 Pathologic Classification of Rejection Jefree J. Schulte
MD and Aliya N. Husain
MD 396 Antibody-Mediated Rejection
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD 398 Acute Cellular Rejection
Grade A Jefree J. Schulte
MD and Aliya N. Husain
MD 400 Acute Cellular Rejection
Grade B Jefree J. Schulte
MD and Aliya N. Husain
MD 402 Chronic Allograft Dysfunction
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD NONINFECTIOUS LESIONS 404 Organizing Pneumonia Jefree J. Schulte
MD and Aliya N. Husain
MD 406 Microaspiration Jefree J. Schulte
MD and Aliya N. Husain
MD INFECTIONS 408 Bacterial Infections Jefree J. Schulte
MD and Aliya N. Husain
MD 410 Viral Infections Jefree J. Schulte
MD and Aliya N. Husain
MD 414 Fungal Infections
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD SECTION 8: INTESTINAL TRANSPLANTATION 420 Pathologic Classification of Intestinal Allograft Diseases Sarangarajan Ranganathan
MD 422 Indications and Evaluation of Explant Sarangarajan Ranganathan
MD 426 Reperfusion Injury Sarangarajan Ranganathan
MD 430 History of Intestinal and Multivisceral Transplantation Sarangarajan Ranganathan
MD ALLOGRAFT REJECTION/IMMUNOLOGICAL INJURY 432 Acute Antibody-Mediated Rejection
Intestine Sarangarajan Ranganathan
MD 436 Acute Cellular Rejection
Intestine Sarangarajan Ranganathan
MD 444 Chronic Rejection
Intestine Sarangarajan Ranganathan
MD 448 Stomach Rejection Sarangarajan Ranganathan
MD 452 Colon Rejection Sarangarajan Ranganathan
MD 456 Graft-vs.-Host Disease
Intestine Sarangarajan Ranganathan
MD INFECTIONS 460 Bacterial and Fungal Infections Sarangarajan Ranganathan
MD 464 Adenovirus
Intestine Sarangarajan Ranganathan
MD 468 Rotavirus
Cytomegalovirus
and Herpes Simplex Virus Sarangarajan Ranganathan
MD 472 Epstein-Barr Virus
Intestine Sarangarajan Ranganathan
MD SECTION 9: PANCREAS TRANSPLANTATION 480 Pathologic Classification of Pancreas Allograft Diseases Surya V. Seshan
MD and Billie S. Fyfe
MD 482 Clinical Considerations in Pancreas Transplant Evaluation Surya V. Seshan
MD and Billie S. Fyfe
MD 488 History of Pancreas Transplantation Surya V. Seshan
MD and Billie S. Fyfe
MD 490 History of Islet Transplantation Piotr Witkowski
MD
PhD and Sarah A. Gondek
BS SURGICAL COMPLICATIONS 492 Surgical Aspects and Complications
Pancreas Piotr Witkowski
MD
PhD
Sarah A. Gondek
BS
and Surya V. Seshan
MD ALLOGRAFT REJECTION 500 T-Cell-Mediated Rejection
Pancreas Surya V. Seshan
MD
Billie S. Fyfe
MD
and Erika R. Bracamonte
MD 506 Antibody-Mediated Rejection
Pancreas Surya V. Seshan
MD and Billie S. Fyfe
MD 510 Pancreas Allograft Fibrosis/Graft Sclerosis Surya V. Seshan
MD
Billie S. Fyfe
MD
and Erika R. Bracamonte
MD GRAFT DYSFUNCTION 514 Recurrent Diabetes Mellitus Surya V. Seshan
MD and Billie S. Fyfe
MD 518 Islet Cell Toxicity and Islet Amyloid Deposition Surya V. Seshan
MD and Billie S. Fyfe
MD INFECTIONS 520 Intraabdominal and Opportunistic Infections Surya V. Seshan
MD and Billie S. Fyfe
MD SECTION 10: VASCULARIZED COMPOSITE ALLOTRANSPLANTATION 528 History of Vascularized Composite Allotransplantation Linda Cendales
MD
J. Andres Hernandez
MD
MBA
and Emmanuel O. Emovon
III
BS 530 Complications of Vascularized Composite Allotransplantation Linda Cendales
MD
J. Andres Hernandez
MD
MBA
and Emmanuel O. Emovon
III
BS ALLOGRAFT REJECTION 532 Acute T-Cell- and Antibody-Mediated Rejection A. Brad Farris
III
MD
MBA
Ivy A. Rosales
MD
and Robert B. Colvin
MD 540 Chronic Rejection A. Brad Farris
III
MD
MBA
Robert B. Colvin
MD
and Ivy A. Rosales
MD SECTION 11: POSTTRANSPLANT NEOPLASTIC DISORDERS 544 Posttransplant Lymphoproliferative Diseases A. Brad Farris
III
MD
MBA
PhD 8 Regulatory Immune Cells and Transplant Tolerance Roshini Sarah Abraham
PhD 14 Viral Infections and Immune Response Sanya J. Thomas
MD and Roshini Sarah Abraham
PhD 20 Genetics of Complement Variants in Atypical HUS and TMA Roshini Sarah Abraham
PhD 24 Laboratory-Based Immune Monitoring in Organ Transplantation Sanya J. Thomas
MD and Roshini Sarah Abraham
PhD 30 Introduction to Xenotransplantation Roshini Sarah Abraham
PhD 32 Graft-vs.-Host Disease in Solid Organ Transplantation Sanya J. Thomas
MD and Roshini Sarah Abraham
PhD SECTION2: HLA TESTING 36 Human Leukocyte Antigen System Manish J. Gandhi
MD 38 Histocompatibility Testing Manish J. Gandhi
MD 40 Transplantation and HLA Manish J. Gandhi
MD 44 ABO Blood Group Antigens and Transplantation Manish J. Gandhi
MD 46 Apheresis and Transplantation Manish J. Gandhi
MD 48 HLA and Transfusion Manish J. Gandhi
MD SECTION 3: IMMUNOSUPPRESSIVE DRUGS 52 Mechanism of Action of Immunosuppressive Drugs Loralie Langman
PhD and Florian Lemaitre
PharmD
PhD 54 Therapeutic Drug Monitoring in Transplant Patients Loralie Langman
PhD and Florian Lemaitre
PharmD
PhD 58 History of Immunosuppression Drugs in Transplantation Loralie Langman
PhD and Florian Lemaitre
PharmD
PhD SECTION 4: KIDNEY TRANSPLANTATION 62 History of Kidney Transplantation Lynn D. Cornell
MD 64 Pathologic Classification of Renal Allograft Diseases Robert B. Colvin
MD 66 Examination of End-Stage Kidney Shane Meehan
MB
BCh 72 Evaluation of End-Stage Kidney Shane Meehan
MB
BCh 78 Evaluation of Allograft Kidney Lynn D. Cornell
MD and Evan Farkash
MD
PhD 84 Evaluation of Donor Kidney Lynn D. Cornell
MD and Evan Farkash
MD
PhD 90 Evaluation of Transplant Nephrectomy Shane Meehan
MB
BCh and Evan Farkash
MD
PhD 94 Evaluation of Fibrosis A. Brad Farris
III
MD
MBA 98 Protocol Biopsies Lynn D. Cornell
MD and Evan Farkash
MD
PhD 102 Accommodation Lynn D. Cornell
MD 104 Tolerance Robert B. Colvin
MD SURGICAL COMPLICATIONS 108 Acute Allograft Ischemia A. Brad Farris
III
MD
MBA 112 Size Mismatch Allograft Injury Anthony Chang
MD and Yael K. Heher
MD
MPH 114 Urine Leak A. Brad Farris
III
MD
MBA 115 Lymphocele A. Brad Farris
III
MD
MBA 116 Multinucleated Endotheliopathy Jonathan Zuckerman
MD
PhD 120 Transplant Renal Artery Stenosis A. Brad Farris
III
MD
MBA 122 Transplant Renal Artery or Vein Thrombosis A. Brad Farris
III
MD
MBA 124 Kidney Xenografts Ivy A. Rosales
MD ALLOGRAFT REJECTION 128 Hyperacute Rejection Lynn D. Cornell
MD and Michael Mengel
MD 132 Acute T-Cell-Mediated Rejection Lynn D. Cornell
MD and Michael Mengel
MD 142 Chronic T-Cell-Mediated Rejection Lynn D. Cornell
MD and Michael Mengel
MD 146 Acute Antibody-Mediated Rejection Lynn D. Cornell
MD and Michael Mengel
MD 154 Chronic Antibody-Mediated Rejection Lynn D. Cornell
MD and Michael Mengel
MD 166 Transcript Analysis of Renal Transplant Biopsies Michael Mengel
MD and R. Neal Smith
MD
PhD RECURRENT AND DE NOVO DISEASES 170 Diseases That Recur in Allografts Anthony Chang
MD
Lynn D. Cornell
MD
and R. Neal Smith
MD
PhD 176 De Novo Focal Segmental Glomerulosclerosis Anthony Chang
MD and Astrid Weins
MD
PhD 178 De Novo Membranous Nephropathy Anthony Chang
MD 182 Anti-GBM Disease in Alport Syndrome Anthony Chang
MD and R. Neal Smith
MD
PhD 184 Chimerism Transition Syndrome A. Brad Farris
III
MD
MBA 186 Late Posttransplant Histology Lynn D. Cornell
MD KIDNEY PATHOLOGY OF RECIPIENTS OF OTHER TRANSPLANTS 188 Kidney Diseases in Nonrenal Transplant Recipients Robert B. Colvin
MD 192 Graft-vs.-Host Glomerulopathies Anthony Chang
MD and Yael K. Heher
MD
MPH DRUG TOXICITIES 194 Calcineurin Inhibitor Toxicity Shane Meehan
MB
BCh 200 mTOR Inhibitor Toxicity Lynn D. Cornell
MD INFECTIONS 202 Acute Pyelonephritis Neeraja Kambham
MD 210 Polyomavirus Nephritis Anthony Chang
MD and Evan Farkash
MD
PhD 218 Adenovirus Infection Anthony Chang
MD and R. Neal Smith
MD
PhD 220 Cytomegalovirus Infection Anthony Chang
MD and R. Neal Smith
MD
PhD 222 Mucormycosis Anthony Chang
MD 224 Histoplasmosis Anthony Chang
MD 225 Candidiasis Anthony Chang
MD 226 Cryptococcosis Anthony Chang
MD 227 Aspergillosis Anthony Chang
MD 228 Coccidioidomycosis Anthony Chang
MD 229 Paracoccidioidomycosis Anthony Chang
MD 230 Microsporidiosis Robert B. Colvin
MD 232 Tuberculosis Neeraja Kambham
MD 234 Malakoplakia Neeraja Kambham
MD 238 Nocardiosis Neeraja Kambham
MD SECTION 5: LIVER TRANSPLANTATION 242 Pathologic Classification of Liver Allograft Diseases Lindsay Alpert
MD and John Hart
MD 244 Gross Evaluation of Native Liver Lindsay Alpert
MD and John Hart
MD 248 Evaluation of Failed Liver Allograft Lindsay Alpert
MD and John Hart
MD 250 Evaluation of Donor Liver John Hart
MD 254 History of Liver Transplantation Anthony Chang
MD and John Hart
MD POSTTRANSPLANT SURGICAL COMPLICATIONS 256 Preservation Injury Hanlin L. Wang
MD
PhD 258 Hepatic Artery Thrombosis Lisa Yerian
MD and John Hart
MD 260 Portal Vein Thrombosis Lisa Yerian
MD and John Hart
MD 262 Bile Duct Stricture
Leak
Sludge
Biloma Hanlin L. Wang
MD
PhD 264 Hepatic Venous Outflow Obstruction Hanlin L. Wang
MD
PhD 268 Small-for-Size (Hyperperfusion) Syndrome Hanlin L. Wang
MD
PhD ALLOGRAFT REJECTION 270 T-Cell-Mediated Rejection
Liver Lisa Yerian
MD and John Hart
MD 274 Antibody-Mediated Rejection
Liver Hanlin L. Wang
MD
PhD
Robert B. Colvin
MD
and Richard Masia
MD
PhD 278 Chronic (Ductopenic) Rejection Matthew M. Yeh
MD
PhD and John Hart
MD RECURRENT DISEASES IN LIVER ALLOGRAFT 280 Recurrent Hepatitis B Virus Lindsay Alpert
MD and John Hart
MD 282 Recurrent Hepatitis C Virus Lindsay Alpert
MD and John Hart
MD 286 Fibrosing Cholestatic HBV or HCV Hepatitis Lindsay Alpert
MD and John Hart
MD 288 Recurrent Autoimmune Hepatitis Lindsay Alpert
MD and John Hart
MD 290 Recurrent Primary Biliary Cholangitis Lindsay Alpert
MD and John Hart
MD 292 Recurrent Primary Sclerosing Cholangitis Lindsay Alpert
MD and John Hart
MD 294 Recurrent Fatty Liver Disease Lindsay Alpert
MD and John Hart
MD INFECTIONS 296 Cytomegalovirus Maria Westerhoff
MD and Lei Zhao
MD
PhD 298 Herpes Simplex Virus Maria Westerhoff
MD and Lei Zhao
MD
PhD 300 Adenovirus
Liver Maria Westerhoff
MD and Lei Zhao
MD
PhD 302 Hepatitis E Virus Maria Westerhoff
MD and Lei Zhao
MD
PhD 304 Epstein-Barr Virus
Liver Maria Westerhoff
MD and Lei Zhao
MD
PhD 308 Fungal Infections
Liver Maria Westerhoff
MD and Lei Zhao
MD
PhD LATE-GRAFT DYSFUNCTION 310 Plasma Cell-Rich Rejection Lisa Yerian
MD and John Hart
MD 312 Graft-vs.-Host Disease
Liver Lisa Yerian
MD and John Hart
MD SECTION 6: HEART TRANSPLANTATION 316 Pathologic Classification of Cardiac Allograft Diseases Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 318 Evaluation of Failed Native and Transplanted Heart Aliya N. Husain
MD and Phillip D. McMullen
MD
PhD 320 History of Heart Transplantation Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD EVALUATION OF EXPLANTED HEART 322 Ischemic Heart Disease Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 326 Dilated Cardiomyopathy Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 330 Hypertrophic Cardiomyopathy Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 334 Congenital Heart Disease Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 338 Sarcoidosis
Heart Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 340 Arrhythmogenic Cardiomyopathy Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 344 Other Causes of End-Stage Heart Disease Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD ALLOGRAFT REJECTION 350 Acute Cellular Rejection
Heart Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 354 Antibody-Mediated Rejection
Heart Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 356 Chronic Allograft Vasculopathy
Heart Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD NONINFECTIOUS LESIONS 358 Quilty Lesions Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 360 Site of Previous Biopsy Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD INFECTIONS 362 Myocarditis Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD SECTION 7: LUNG TRANSPLANTATION 370 Pathologic Classification of Lung Allograft Diseases Jefree J. Schulte
MD and Aliya N. Husain
MD 372 Examination of Native and Transplanted Lungs Jefree J. Schulte
MD and Aliya N. Husain
MD 374 History of Lung Transplantation Jefree J. Schulte
MD and Aliya N. Husain
MD EVALUATION OF FAILED NATIVE LUNG 376 Emphysema Jefree J. Schulte
MD and Aliya N. Husain
MD 378 Cystic Fibrosis Jefree J. Schulte
MD and Aliya N. Husain
MD 380 Idiopathic Pulmonary Fibrosis Jefree J. Schulte
MD and Aliya N. Husain
MD 382 Connective Tissue Disease-Associated Interstitial Lung Disease Jefree J. Schulte
MD and Aliya N. Husain
MD 384 Sarcoidosis
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD 386 Pulmonary Arterial Hypertension Jefree J. Schulte
MD and Aliya N. Husain
MD 388 Other Causes of End-Stage Lung Disease Jefree J. Schulte
MD and Aliya N. Husain
MD SURGICAL COMPLICATIONS 392 Surgical Aspects and Complications
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD ALLOGRAFT REJECTION 394 Pathologic Classification of Rejection Jefree J. Schulte
MD and Aliya N. Husain
MD 396 Antibody-Mediated Rejection
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD 398 Acute Cellular Rejection
Grade A Jefree J. Schulte
MD and Aliya N. Husain
MD 400 Acute Cellular Rejection
Grade B Jefree J. Schulte
MD and Aliya N. Husain
MD 402 Chronic Allograft Dysfunction
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD NONINFECTIOUS LESIONS 404 Organizing Pneumonia Jefree J. Schulte
MD and Aliya N. Husain
MD 406 Microaspiration Jefree J. Schulte
MD and Aliya N. Husain
MD INFECTIONS 408 Bacterial Infections Jefree J. Schulte
MD and Aliya N. Husain
MD 410 Viral Infections Jefree J. Schulte
MD and Aliya N. Husain
MD 414 Fungal Infections
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD SECTION 8: INTESTINAL TRANSPLANTATION 420 Pathologic Classification of Intestinal Allograft Diseases Sarangarajan Ranganathan
MD 422 Indications and Evaluation of Explant Sarangarajan Ranganathan
MD 426 Reperfusion Injury Sarangarajan Ranganathan
MD 430 History of Intestinal and Multivisceral Transplantation Sarangarajan Ranganathan
MD ALLOGRAFT REJECTION/IMMUNOLOGICAL INJURY 432 Acute Antibody-Mediated Rejection
Intestine Sarangarajan Ranganathan
MD 436 Acute Cellular Rejection
Intestine Sarangarajan Ranganathan
MD 444 Chronic Rejection
Intestine Sarangarajan Ranganathan
MD 448 Stomach Rejection Sarangarajan Ranganathan
MD 452 Colon Rejection Sarangarajan Ranganathan
MD 456 Graft-vs.-Host Disease
Intestine Sarangarajan Ranganathan
MD INFECTIONS 460 Bacterial and Fungal Infections Sarangarajan Ranganathan
MD 464 Adenovirus
Intestine Sarangarajan Ranganathan
MD 468 Rotavirus
Cytomegalovirus
and Herpes Simplex Virus Sarangarajan Ranganathan
MD 472 Epstein-Barr Virus
Intestine Sarangarajan Ranganathan
MD SECTION 9: PANCREAS TRANSPLANTATION 480 Pathologic Classification of Pancreas Allograft Diseases Surya V. Seshan
MD and Billie S. Fyfe
MD 482 Clinical Considerations in Pancreas Transplant Evaluation Surya V. Seshan
MD and Billie S. Fyfe
MD 488 History of Pancreas Transplantation Surya V. Seshan
MD and Billie S. Fyfe
MD 490 History of Islet Transplantation Piotr Witkowski
MD
PhD and Sarah A. Gondek
BS SURGICAL COMPLICATIONS 492 Surgical Aspects and Complications
Pancreas Piotr Witkowski
MD
PhD
Sarah A. Gondek
BS
and Surya V. Seshan
MD ALLOGRAFT REJECTION 500 T-Cell-Mediated Rejection
Pancreas Surya V. Seshan
MD
Billie S. Fyfe
MD
and Erika R. Bracamonte
MD 506 Antibody-Mediated Rejection
Pancreas Surya V. Seshan
MD and Billie S. Fyfe
MD 510 Pancreas Allograft Fibrosis/Graft Sclerosis Surya V. Seshan
MD
Billie S. Fyfe
MD
and Erika R. Bracamonte
MD GRAFT DYSFUNCTION 514 Recurrent Diabetes Mellitus Surya V. Seshan
MD and Billie S. Fyfe
MD 518 Islet Cell Toxicity and Islet Amyloid Deposition Surya V. Seshan
MD and Billie S. Fyfe
MD INFECTIONS 520 Intraabdominal and Opportunistic Infections Surya V. Seshan
MD and Billie S. Fyfe
MD SECTION 10: VASCULARIZED COMPOSITE ALLOTRANSPLANTATION 528 History of Vascularized Composite Allotransplantation Linda Cendales
MD
J. Andres Hernandez
MD
MBA
and Emmanuel O. Emovon
III
BS 530 Complications of Vascularized Composite Allotransplantation Linda Cendales
MD
J. Andres Hernandez
MD
MBA
and Emmanuel O. Emovon
III
BS ALLOGRAFT REJECTION 532 Acute T-Cell- and Antibody-Mediated Rejection A. Brad Farris
III
MD
MBA
Ivy A. Rosales
MD
and Robert B. Colvin
MD 540 Chronic Rejection A. Brad Farris
III
MD
MBA
Robert B. Colvin
MD
and Ivy A. Rosales
MD SECTION 11: POSTTRANSPLANT NEOPLASTIC DISORDERS 544 Posttransplant Lymphoproliferative Diseases A. Brad Farris
III
MD
MBA
SECTION 1: IMMUNOLOGY 4 Immune Response in Organ Transplantation Roshini Sarah Abraham
PhD 8 Regulatory Immune Cells and Transplant Tolerance Roshini Sarah Abraham
PhD 14 Viral Infections and Immune Response Sanya J. Thomas
MD and Roshini Sarah Abraham
PhD 20 Genetics of Complement Variants in Atypical HUS and TMA Roshini Sarah Abraham
PhD 24 Laboratory-Based Immune Monitoring in Organ Transplantation Sanya J. Thomas
MD and Roshini Sarah Abraham
PhD 30 Introduction to Xenotransplantation Roshini Sarah Abraham
PhD 32 Graft-vs.-Host Disease in Solid Organ Transplantation Sanya J. Thomas
MD and Roshini Sarah Abraham
PhD SECTION2: HLA TESTING 36 Human Leukocyte Antigen System Manish J. Gandhi
MD 38 Histocompatibility Testing Manish J. Gandhi
MD 40 Transplantation and HLA Manish J. Gandhi
MD 44 ABO Blood Group Antigens and Transplantation Manish J. Gandhi
MD 46 Apheresis and Transplantation Manish J. Gandhi
MD 48 HLA and Transfusion Manish J. Gandhi
MD SECTION 3: IMMUNOSUPPRESSIVE DRUGS 52 Mechanism of Action of Immunosuppressive Drugs Loralie Langman
PhD and Florian Lemaitre
PharmD
PhD 54 Therapeutic Drug Monitoring in Transplant Patients Loralie Langman
PhD and Florian Lemaitre
PharmD
PhD 58 History of Immunosuppression Drugs in Transplantation Loralie Langman
PhD and Florian Lemaitre
PharmD
PhD SECTION 4: KIDNEY TRANSPLANTATION 62 History of Kidney Transplantation Lynn D. Cornell
MD 64 Pathologic Classification of Renal Allograft Diseases Robert B. Colvin
MD 66 Examination of End-Stage Kidney Shane Meehan
MB
BCh 72 Evaluation of End-Stage Kidney Shane Meehan
MB
BCh 78 Evaluation of Allograft Kidney Lynn D. Cornell
MD and Evan Farkash
MD
PhD 84 Evaluation of Donor Kidney Lynn D. Cornell
MD and Evan Farkash
MD
PhD 90 Evaluation of Transplant Nephrectomy Shane Meehan
MB
BCh and Evan Farkash
MD
PhD 94 Evaluation of Fibrosis A. Brad Farris
III
MD
MBA 98 Protocol Biopsies Lynn D. Cornell
MD and Evan Farkash
MD
PhD 102 Accommodation Lynn D. Cornell
MD 104 Tolerance Robert B. Colvin
MD SURGICAL COMPLICATIONS 108 Acute Allograft Ischemia A. Brad Farris
III
MD
MBA 112 Size Mismatch Allograft Injury Anthony Chang
MD and Yael K. Heher
MD
MPH 114 Urine Leak A. Brad Farris
III
MD
MBA 115 Lymphocele A. Brad Farris
III
MD
MBA 116 Multinucleated Endotheliopathy Jonathan Zuckerman
MD
PhD 120 Transplant Renal Artery Stenosis A. Brad Farris
III
MD
MBA 122 Transplant Renal Artery or Vein Thrombosis A. Brad Farris
III
MD
MBA 124 Kidney Xenografts Ivy A. Rosales
MD ALLOGRAFT REJECTION 128 Hyperacute Rejection Lynn D. Cornell
MD and Michael Mengel
MD 132 Acute T-Cell-Mediated Rejection Lynn D. Cornell
MD and Michael Mengel
MD 142 Chronic T-Cell-Mediated Rejection Lynn D. Cornell
MD and Michael Mengel
MD 146 Acute Antibody-Mediated Rejection Lynn D. Cornell
MD and Michael Mengel
MD 154 Chronic Antibody-Mediated Rejection Lynn D. Cornell
MD and Michael Mengel
MD 166 Transcript Analysis of Renal Transplant Biopsies Michael Mengel
MD and R. Neal Smith
MD
PhD RECURRENT AND DE NOVO DISEASES 170 Diseases That Recur in Allografts Anthony Chang
MD
Lynn D. Cornell
MD
and R. Neal Smith
MD
PhD 176 De Novo Focal Segmental Glomerulosclerosis Anthony Chang
MD and Astrid Weins
MD
PhD 178 De Novo Membranous Nephropathy Anthony Chang
MD 182 Anti-GBM Disease in Alport Syndrome Anthony Chang
MD and R. Neal Smith
MD
PhD 184 Chimerism Transition Syndrome A. Brad Farris
III
MD
MBA 186 Late Posttransplant Histology Lynn D. Cornell
MD KIDNEY PATHOLOGY OF RECIPIENTS OF OTHER TRANSPLANTS 188 Kidney Diseases in Nonrenal Transplant Recipients Robert B. Colvin
MD 192 Graft-vs.-Host Glomerulopathies Anthony Chang
MD and Yael K. Heher
MD
MPH DRUG TOXICITIES 194 Calcineurin Inhibitor Toxicity Shane Meehan
MB
BCh 200 mTOR Inhibitor Toxicity Lynn D. Cornell
MD INFECTIONS 202 Acute Pyelonephritis Neeraja Kambham
MD 210 Polyomavirus Nephritis Anthony Chang
MD and Evan Farkash
MD
PhD 218 Adenovirus Infection Anthony Chang
MD and R. Neal Smith
MD
PhD 220 Cytomegalovirus Infection Anthony Chang
MD and R. Neal Smith
MD
PhD 222 Mucormycosis Anthony Chang
MD 224 Histoplasmosis Anthony Chang
MD 225 Candidiasis Anthony Chang
MD 226 Cryptococcosis Anthony Chang
MD 227 Aspergillosis Anthony Chang
MD 228 Coccidioidomycosis Anthony Chang
MD 229 Paracoccidioidomycosis Anthony Chang
MD 230 Microsporidiosis Robert B. Colvin
MD 232 Tuberculosis Neeraja Kambham
MD 234 Malakoplakia Neeraja Kambham
MD 238 Nocardiosis Neeraja Kambham
MD SECTION 5: LIVER TRANSPLANTATION 242 Pathologic Classification of Liver Allograft Diseases Lindsay Alpert
MD and John Hart
MD 244 Gross Evaluation of Native Liver Lindsay Alpert
MD and John Hart
MD 248 Evaluation of Failed Liver Allograft Lindsay Alpert
MD and John Hart
MD 250 Evaluation of Donor Liver John Hart
MD 254 History of Liver Transplantation Anthony Chang
MD and John Hart
MD POSTTRANSPLANT SURGICAL COMPLICATIONS 256 Preservation Injury Hanlin L. Wang
MD
PhD 258 Hepatic Artery Thrombosis Lisa Yerian
MD and John Hart
MD 260 Portal Vein Thrombosis Lisa Yerian
MD and John Hart
MD 262 Bile Duct Stricture
Leak
Sludge
Biloma Hanlin L. Wang
MD
PhD 264 Hepatic Venous Outflow Obstruction Hanlin L. Wang
MD
PhD 268 Small-for-Size (Hyperperfusion) Syndrome Hanlin L. Wang
MD
PhD ALLOGRAFT REJECTION 270 T-Cell-Mediated Rejection
Liver Lisa Yerian
MD and John Hart
MD 274 Antibody-Mediated Rejection
Liver Hanlin L. Wang
MD
PhD
Robert B. Colvin
MD
and Richard Masia
MD
PhD 278 Chronic (Ductopenic) Rejection Matthew M. Yeh
MD
PhD and John Hart
MD RECURRENT DISEASES IN LIVER ALLOGRAFT 280 Recurrent Hepatitis B Virus Lindsay Alpert
MD and John Hart
MD 282 Recurrent Hepatitis C Virus Lindsay Alpert
MD and John Hart
MD 286 Fibrosing Cholestatic HBV or HCV Hepatitis Lindsay Alpert
MD and John Hart
MD 288 Recurrent Autoimmune Hepatitis Lindsay Alpert
MD and John Hart
MD 290 Recurrent Primary Biliary Cholangitis Lindsay Alpert
MD and John Hart
MD 292 Recurrent Primary Sclerosing Cholangitis Lindsay Alpert
MD and John Hart
MD 294 Recurrent Fatty Liver Disease Lindsay Alpert
MD and John Hart
MD INFECTIONS 296 Cytomegalovirus Maria Westerhoff
MD and Lei Zhao
MD
PhD 298 Herpes Simplex Virus Maria Westerhoff
MD and Lei Zhao
MD
PhD 300 Adenovirus
Liver Maria Westerhoff
MD and Lei Zhao
MD
PhD 302 Hepatitis E Virus Maria Westerhoff
MD and Lei Zhao
MD
PhD 304 Epstein-Barr Virus
Liver Maria Westerhoff
MD and Lei Zhao
MD
PhD 308 Fungal Infections
Liver Maria Westerhoff
MD and Lei Zhao
MD
PhD LATE-GRAFT DYSFUNCTION 310 Plasma Cell-Rich Rejection Lisa Yerian
MD and John Hart
MD 312 Graft-vs.-Host Disease
Liver Lisa Yerian
MD and John Hart
MD SECTION 6: HEART TRANSPLANTATION 316 Pathologic Classification of Cardiac Allograft Diseases Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 318 Evaluation of Failed Native and Transplanted Heart Aliya N. Husain
MD and Phillip D. McMullen
MD
PhD 320 History of Heart Transplantation Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD EVALUATION OF EXPLANTED HEART 322 Ischemic Heart Disease Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 326 Dilated Cardiomyopathy Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 330 Hypertrophic Cardiomyopathy Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 334 Congenital Heart Disease Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 338 Sarcoidosis
Heart Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 340 Arrhythmogenic Cardiomyopathy Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 344 Other Causes of End-Stage Heart Disease Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD ALLOGRAFT REJECTION 350 Acute Cellular Rejection
Heart Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 354 Antibody-Mediated Rejection
Heart Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 356 Chronic Allograft Vasculopathy
Heart Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD NONINFECTIOUS LESIONS 358 Quilty Lesions Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 360 Site of Previous Biopsy Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD INFECTIONS 362 Myocarditis Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD SECTION 7: LUNG TRANSPLANTATION 370 Pathologic Classification of Lung Allograft Diseases Jefree J. Schulte
MD and Aliya N. Husain
MD 372 Examination of Native and Transplanted Lungs Jefree J. Schulte
MD and Aliya N. Husain
MD 374 History of Lung Transplantation Jefree J. Schulte
MD and Aliya N. Husain
MD EVALUATION OF FAILED NATIVE LUNG 376 Emphysema Jefree J. Schulte
MD and Aliya N. Husain
MD 378 Cystic Fibrosis Jefree J. Schulte
MD and Aliya N. Husain
MD 380 Idiopathic Pulmonary Fibrosis Jefree J. Schulte
MD and Aliya N. Husain
MD 382 Connective Tissue Disease-Associated Interstitial Lung Disease Jefree J. Schulte
MD and Aliya N. Husain
MD 384 Sarcoidosis
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD 386 Pulmonary Arterial Hypertension Jefree J. Schulte
MD and Aliya N. Husain
MD 388 Other Causes of End-Stage Lung Disease Jefree J. Schulte
MD and Aliya N. Husain
MD SURGICAL COMPLICATIONS 392 Surgical Aspects and Complications
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD ALLOGRAFT REJECTION 394 Pathologic Classification of Rejection Jefree J. Schulte
MD and Aliya N. Husain
MD 396 Antibody-Mediated Rejection
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD 398 Acute Cellular Rejection
Grade A Jefree J. Schulte
MD and Aliya N. Husain
MD 400 Acute Cellular Rejection
Grade B Jefree J. Schulte
MD and Aliya N. Husain
MD 402 Chronic Allograft Dysfunction
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD NONINFECTIOUS LESIONS 404 Organizing Pneumonia Jefree J. Schulte
MD and Aliya N. Husain
MD 406 Microaspiration Jefree J. Schulte
MD and Aliya N. Husain
MD INFECTIONS 408 Bacterial Infections Jefree J. Schulte
MD and Aliya N. Husain
MD 410 Viral Infections Jefree J. Schulte
MD and Aliya N. Husain
MD 414 Fungal Infections
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD SECTION 8: INTESTINAL TRANSPLANTATION 420 Pathologic Classification of Intestinal Allograft Diseases Sarangarajan Ranganathan
MD 422 Indications and Evaluation of Explant Sarangarajan Ranganathan
MD 426 Reperfusion Injury Sarangarajan Ranganathan
MD 430 History of Intestinal and Multivisceral Transplantation Sarangarajan Ranganathan
MD ALLOGRAFT REJECTION/IMMUNOLOGICAL INJURY 432 Acute Antibody-Mediated Rejection
Intestine Sarangarajan Ranganathan
MD 436 Acute Cellular Rejection
Intestine Sarangarajan Ranganathan
MD 444 Chronic Rejection
Intestine Sarangarajan Ranganathan
MD 448 Stomach Rejection Sarangarajan Ranganathan
MD 452 Colon Rejection Sarangarajan Ranganathan
MD 456 Graft-vs.-Host Disease
Intestine Sarangarajan Ranganathan
MD INFECTIONS 460 Bacterial and Fungal Infections Sarangarajan Ranganathan
MD 464 Adenovirus
Intestine Sarangarajan Ranganathan
MD 468 Rotavirus
Cytomegalovirus
and Herpes Simplex Virus Sarangarajan Ranganathan
MD 472 Epstein-Barr Virus
Intestine Sarangarajan Ranganathan
MD SECTION 9: PANCREAS TRANSPLANTATION 480 Pathologic Classification of Pancreas Allograft Diseases Surya V. Seshan
MD and Billie S. Fyfe
MD 482 Clinical Considerations in Pancreas Transplant Evaluation Surya V. Seshan
MD and Billie S. Fyfe
MD 488 History of Pancreas Transplantation Surya V. Seshan
MD and Billie S. Fyfe
MD 490 History of Islet Transplantation Piotr Witkowski
MD
PhD and Sarah A. Gondek
BS SURGICAL COMPLICATIONS 492 Surgical Aspects and Complications
Pancreas Piotr Witkowski
MD
PhD
Sarah A. Gondek
BS
and Surya V. Seshan
MD ALLOGRAFT REJECTION 500 T-Cell-Mediated Rejection
Pancreas Surya V. Seshan
MD
Billie S. Fyfe
MD
and Erika R. Bracamonte
MD 506 Antibody-Mediated Rejection
Pancreas Surya V. Seshan
MD and Billie S. Fyfe
MD 510 Pancreas Allograft Fibrosis/Graft Sclerosis Surya V. Seshan
MD
Billie S. Fyfe
MD
and Erika R. Bracamonte
MD GRAFT DYSFUNCTION 514 Recurrent Diabetes Mellitus Surya V. Seshan
MD and Billie S. Fyfe
MD 518 Islet Cell Toxicity and Islet Amyloid Deposition Surya V. Seshan
MD and Billie S. Fyfe
MD INFECTIONS 520 Intraabdominal and Opportunistic Infections Surya V. Seshan
MD and Billie S. Fyfe
MD SECTION 10: VASCULARIZED COMPOSITE ALLOTRANSPLANTATION 528 History of Vascularized Composite Allotransplantation Linda Cendales
MD
J. Andres Hernandez
MD
MBA
and Emmanuel O. Emovon
III
BS 530 Complications of Vascularized Composite Allotransplantation Linda Cendales
MD
J. Andres Hernandez
MD
MBA
and Emmanuel O. Emovon
III
BS ALLOGRAFT REJECTION 532 Acute T-Cell- and Antibody-Mediated Rejection A. Brad Farris
III
MD
MBA
Ivy A. Rosales
MD
and Robert B. Colvin
MD 540 Chronic Rejection A. Brad Farris
III
MD
MBA
Robert B. Colvin
MD
and Ivy A. Rosales
MD SECTION 11: POSTTRANSPLANT NEOPLASTIC DISORDERS 544 Posttransplant Lymphoproliferative Diseases A. Brad Farris
III
MD
MBA
PhD 8 Regulatory Immune Cells and Transplant Tolerance Roshini Sarah Abraham
PhD 14 Viral Infections and Immune Response Sanya J. Thomas
MD and Roshini Sarah Abraham
PhD 20 Genetics of Complement Variants in Atypical HUS and TMA Roshini Sarah Abraham
PhD 24 Laboratory-Based Immune Monitoring in Organ Transplantation Sanya J. Thomas
MD and Roshini Sarah Abraham
PhD 30 Introduction to Xenotransplantation Roshini Sarah Abraham
PhD 32 Graft-vs.-Host Disease in Solid Organ Transplantation Sanya J. Thomas
MD and Roshini Sarah Abraham
PhD SECTION2: HLA TESTING 36 Human Leukocyte Antigen System Manish J. Gandhi
MD 38 Histocompatibility Testing Manish J. Gandhi
MD 40 Transplantation and HLA Manish J. Gandhi
MD 44 ABO Blood Group Antigens and Transplantation Manish J. Gandhi
MD 46 Apheresis and Transplantation Manish J. Gandhi
MD 48 HLA and Transfusion Manish J. Gandhi
MD SECTION 3: IMMUNOSUPPRESSIVE DRUGS 52 Mechanism of Action of Immunosuppressive Drugs Loralie Langman
PhD and Florian Lemaitre
PharmD
PhD 54 Therapeutic Drug Monitoring in Transplant Patients Loralie Langman
PhD and Florian Lemaitre
PharmD
PhD 58 History of Immunosuppression Drugs in Transplantation Loralie Langman
PhD and Florian Lemaitre
PharmD
PhD SECTION 4: KIDNEY TRANSPLANTATION 62 History of Kidney Transplantation Lynn D. Cornell
MD 64 Pathologic Classification of Renal Allograft Diseases Robert B. Colvin
MD 66 Examination of End-Stage Kidney Shane Meehan
MB
BCh 72 Evaluation of End-Stage Kidney Shane Meehan
MB
BCh 78 Evaluation of Allograft Kidney Lynn D. Cornell
MD and Evan Farkash
MD
PhD 84 Evaluation of Donor Kidney Lynn D. Cornell
MD and Evan Farkash
MD
PhD 90 Evaluation of Transplant Nephrectomy Shane Meehan
MB
BCh and Evan Farkash
MD
PhD 94 Evaluation of Fibrosis A. Brad Farris
III
MD
MBA 98 Protocol Biopsies Lynn D. Cornell
MD and Evan Farkash
MD
PhD 102 Accommodation Lynn D. Cornell
MD 104 Tolerance Robert B. Colvin
MD SURGICAL COMPLICATIONS 108 Acute Allograft Ischemia A. Brad Farris
III
MD
MBA 112 Size Mismatch Allograft Injury Anthony Chang
MD and Yael K. Heher
MD
MPH 114 Urine Leak A. Brad Farris
III
MD
MBA 115 Lymphocele A. Brad Farris
III
MD
MBA 116 Multinucleated Endotheliopathy Jonathan Zuckerman
MD
PhD 120 Transplant Renal Artery Stenosis A. Brad Farris
III
MD
MBA 122 Transplant Renal Artery or Vein Thrombosis A. Brad Farris
III
MD
MBA 124 Kidney Xenografts Ivy A. Rosales
MD ALLOGRAFT REJECTION 128 Hyperacute Rejection Lynn D. Cornell
MD and Michael Mengel
MD 132 Acute T-Cell-Mediated Rejection Lynn D. Cornell
MD and Michael Mengel
MD 142 Chronic T-Cell-Mediated Rejection Lynn D. Cornell
MD and Michael Mengel
MD 146 Acute Antibody-Mediated Rejection Lynn D. Cornell
MD and Michael Mengel
MD 154 Chronic Antibody-Mediated Rejection Lynn D. Cornell
MD and Michael Mengel
MD 166 Transcript Analysis of Renal Transplant Biopsies Michael Mengel
MD and R. Neal Smith
MD
PhD RECURRENT AND DE NOVO DISEASES 170 Diseases That Recur in Allografts Anthony Chang
MD
Lynn D. Cornell
MD
and R. Neal Smith
MD
PhD 176 De Novo Focal Segmental Glomerulosclerosis Anthony Chang
MD and Astrid Weins
MD
PhD 178 De Novo Membranous Nephropathy Anthony Chang
MD 182 Anti-GBM Disease in Alport Syndrome Anthony Chang
MD and R. Neal Smith
MD
PhD 184 Chimerism Transition Syndrome A. Brad Farris
III
MD
MBA 186 Late Posttransplant Histology Lynn D. Cornell
MD KIDNEY PATHOLOGY OF RECIPIENTS OF OTHER TRANSPLANTS 188 Kidney Diseases in Nonrenal Transplant Recipients Robert B. Colvin
MD 192 Graft-vs.-Host Glomerulopathies Anthony Chang
MD and Yael K. Heher
MD
MPH DRUG TOXICITIES 194 Calcineurin Inhibitor Toxicity Shane Meehan
MB
BCh 200 mTOR Inhibitor Toxicity Lynn D. Cornell
MD INFECTIONS 202 Acute Pyelonephritis Neeraja Kambham
MD 210 Polyomavirus Nephritis Anthony Chang
MD and Evan Farkash
MD
PhD 218 Adenovirus Infection Anthony Chang
MD and R. Neal Smith
MD
PhD 220 Cytomegalovirus Infection Anthony Chang
MD and R. Neal Smith
MD
PhD 222 Mucormycosis Anthony Chang
MD 224 Histoplasmosis Anthony Chang
MD 225 Candidiasis Anthony Chang
MD 226 Cryptococcosis Anthony Chang
MD 227 Aspergillosis Anthony Chang
MD 228 Coccidioidomycosis Anthony Chang
MD 229 Paracoccidioidomycosis Anthony Chang
MD 230 Microsporidiosis Robert B. Colvin
MD 232 Tuberculosis Neeraja Kambham
MD 234 Malakoplakia Neeraja Kambham
MD 238 Nocardiosis Neeraja Kambham
MD SECTION 5: LIVER TRANSPLANTATION 242 Pathologic Classification of Liver Allograft Diseases Lindsay Alpert
MD and John Hart
MD 244 Gross Evaluation of Native Liver Lindsay Alpert
MD and John Hart
MD 248 Evaluation of Failed Liver Allograft Lindsay Alpert
MD and John Hart
MD 250 Evaluation of Donor Liver John Hart
MD 254 History of Liver Transplantation Anthony Chang
MD and John Hart
MD POSTTRANSPLANT SURGICAL COMPLICATIONS 256 Preservation Injury Hanlin L. Wang
MD
PhD 258 Hepatic Artery Thrombosis Lisa Yerian
MD and John Hart
MD 260 Portal Vein Thrombosis Lisa Yerian
MD and John Hart
MD 262 Bile Duct Stricture
Leak
Sludge
Biloma Hanlin L. Wang
MD
PhD 264 Hepatic Venous Outflow Obstruction Hanlin L. Wang
MD
PhD 268 Small-for-Size (Hyperperfusion) Syndrome Hanlin L. Wang
MD
PhD ALLOGRAFT REJECTION 270 T-Cell-Mediated Rejection
Liver Lisa Yerian
MD and John Hart
MD 274 Antibody-Mediated Rejection
Liver Hanlin L. Wang
MD
PhD
Robert B. Colvin
MD
and Richard Masia
MD
PhD 278 Chronic (Ductopenic) Rejection Matthew M. Yeh
MD
PhD and John Hart
MD RECURRENT DISEASES IN LIVER ALLOGRAFT 280 Recurrent Hepatitis B Virus Lindsay Alpert
MD and John Hart
MD 282 Recurrent Hepatitis C Virus Lindsay Alpert
MD and John Hart
MD 286 Fibrosing Cholestatic HBV or HCV Hepatitis Lindsay Alpert
MD and John Hart
MD 288 Recurrent Autoimmune Hepatitis Lindsay Alpert
MD and John Hart
MD 290 Recurrent Primary Biliary Cholangitis Lindsay Alpert
MD and John Hart
MD 292 Recurrent Primary Sclerosing Cholangitis Lindsay Alpert
MD and John Hart
MD 294 Recurrent Fatty Liver Disease Lindsay Alpert
MD and John Hart
MD INFECTIONS 296 Cytomegalovirus Maria Westerhoff
MD and Lei Zhao
MD
PhD 298 Herpes Simplex Virus Maria Westerhoff
MD and Lei Zhao
MD
PhD 300 Adenovirus
Liver Maria Westerhoff
MD and Lei Zhao
MD
PhD 302 Hepatitis E Virus Maria Westerhoff
MD and Lei Zhao
MD
PhD 304 Epstein-Barr Virus
Liver Maria Westerhoff
MD and Lei Zhao
MD
PhD 308 Fungal Infections
Liver Maria Westerhoff
MD and Lei Zhao
MD
PhD LATE-GRAFT DYSFUNCTION 310 Plasma Cell-Rich Rejection Lisa Yerian
MD and John Hart
MD 312 Graft-vs.-Host Disease
Liver Lisa Yerian
MD and John Hart
MD SECTION 6: HEART TRANSPLANTATION 316 Pathologic Classification of Cardiac Allograft Diseases Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 318 Evaluation of Failed Native and Transplanted Heart Aliya N. Husain
MD and Phillip D. McMullen
MD
PhD 320 History of Heart Transplantation Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD EVALUATION OF EXPLANTED HEART 322 Ischemic Heart Disease Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 326 Dilated Cardiomyopathy Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 330 Hypertrophic Cardiomyopathy Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 334 Congenital Heart Disease Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 338 Sarcoidosis
Heart Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 340 Arrhythmogenic Cardiomyopathy Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 344 Other Causes of End-Stage Heart Disease Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD ALLOGRAFT REJECTION 350 Acute Cellular Rejection
Heart Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 354 Antibody-Mediated Rejection
Heart Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 356 Chronic Allograft Vasculopathy
Heart Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD NONINFECTIOUS LESIONS 358 Quilty Lesions Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD 360 Site of Previous Biopsy Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD INFECTIONS 362 Myocarditis Phillip D. McMullen
MD
PhD and Aliya N. Husain
MD SECTION 7: LUNG TRANSPLANTATION 370 Pathologic Classification of Lung Allograft Diseases Jefree J. Schulte
MD and Aliya N. Husain
MD 372 Examination of Native and Transplanted Lungs Jefree J. Schulte
MD and Aliya N. Husain
MD 374 History of Lung Transplantation Jefree J. Schulte
MD and Aliya N. Husain
MD EVALUATION OF FAILED NATIVE LUNG 376 Emphysema Jefree J. Schulte
MD and Aliya N. Husain
MD 378 Cystic Fibrosis Jefree J. Schulte
MD and Aliya N. Husain
MD 380 Idiopathic Pulmonary Fibrosis Jefree J. Schulte
MD and Aliya N. Husain
MD 382 Connective Tissue Disease-Associated Interstitial Lung Disease Jefree J. Schulte
MD and Aliya N. Husain
MD 384 Sarcoidosis
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD 386 Pulmonary Arterial Hypertension Jefree J. Schulte
MD and Aliya N. Husain
MD 388 Other Causes of End-Stage Lung Disease Jefree J. Schulte
MD and Aliya N. Husain
MD SURGICAL COMPLICATIONS 392 Surgical Aspects and Complications
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD ALLOGRAFT REJECTION 394 Pathologic Classification of Rejection Jefree J. Schulte
MD and Aliya N. Husain
MD 396 Antibody-Mediated Rejection
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD 398 Acute Cellular Rejection
Grade A Jefree J. Schulte
MD and Aliya N. Husain
MD 400 Acute Cellular Rejection
Grade B Jefree J. Schulte
MD and Aliya N. Husain
MD 402 Chronic Allograft Dysfunction
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD NONINFECTIOUS LESIONS 404 Organizing Pneumonia Jefree J. Schulte
MD and Aliya N. Husain
MD 406 Microaspiration Jefree J. Schulte
MD and Aliya N. Husain
MD INFECTIONS 408 Bacterial Infections Jefree J. Schulte
MD and Aliya N. Husain
MD 410 Viral Infections Jefree J. Schulte
MD and Aliya N. Husain
MD 414 Fungal Infections
Lung Jefree J. Schulte
MD and Aliya N. Husain
MD SECTION 8: INTESTINAL TRANSPLANTATION 420 Pathologic Classification of Intestinal Allograft Diseases Sarangarajan Ranganathan
MD 422 Indications and Evaluation of Explant Sarangarajan Ranganathan
MD 426 Reperfusion Injury Sarangarajan Ranganathan
MD 430 History of Intestinal and Multivisceral Transplantation Sarangarajan Ranganathan
MD ALLOGRAFT REJECTION/IMMUNOLOGICAL INJURY 432 Acute Antibody-Mediated Rejection
Intestine Sarangarajan Ranganathan
MD 436 Acute Cellular Rejection
Intestine Sarangarajan Ranganathan
MD 444 Chronic Rejection
Intestine Sarangarajan Ranganathan
MD 448 Stomach Rejection Sarangarajan Ranganathan
MD 452 Colon Rejection Sarangarajan Ranganathan
MD 456 Graft-vs.-Host Disease
Intestine Sarangarajan Ranganathan
MD INFECTIONS 460 Bacterial and Fungal Infections Sarangarajan Ranganathan
MD 464 Adenovirus
Intestine Sarangarajan Ranganathan
MD 468 Rotavirus
Cytomegalovirus
and Herpes Simplex Virus Sarangarajan Ranganathan
MD 472 Epstein-Barr Virus
Intestine Sarangarajan Ranganathan
MD SECTION 9: PANCREAS TRANSPLANTATION 480 Pathologic Classification of Pancreas Allograft Diseases Surya V. Seshan
MD and Billie S. Fyfe
MD 482 Clinical Considerations in Pancreas Transplant Evaluation Surya V. Seshan
MD and Billie S. Fyfe
MD 488 History of Pancreas Transplantation Surya V. Seshan
MD and Billie S. Fyfe
MD 490 History of Islet Transplantation Piotr Witkowski
MD
PhD and Sarah A. Gondek
BS SURGICAL COMPLICATIONS 492 Surgical Aspects and Complications
Pancreas Piotr Witkowski
MD
PhD
Sarah A. Gondek
BS
and Surya V. Seshan
MD ALLOGRAFT REJECTION 500 T-Cell-Mediated Rejection
Pancreas Surya V. Seshan
MD
Billie S. Fyfe
MD
and Erika R. Bracamonte
MD 506 Antibody-Mediated Rejection
Pancreas Surya V. Seshan
MD and Billie S. Fyfe
MD 510 Pancreas Allograft Fibrosis/Graft Sclerosis Surya V. Seshan
MD
Billie S. Fyfe
MD
and Erika R. Bracamonte
MD GRAFT DYSFUNCTION 514 Recurrent Diabetes Mellitus Surya V. Seshan
MD and Billie S. Fyfe
MD 518 Islet Cell Toxicity and Islet Amyloid Deposition Surya V. Seshan
MD and Billie S. Fyfe
MD INFECTIONS 520 Intraabdominal and Opportunistic Infections Surya V. Seshan
MD and Billie S. Fyfe
MD SECTION 10: VASCULARIZED COMPOSITE ALLOTRANSPLANTATION 528 History of Vascularized Composite Allotransplantation Linda Cendales
MD
J. Andres Hernandez
MD
MBA
and Emmanuel O. Emovon
III
BS 530 Complications of Vascularized Composite Allotransplantation Linda Cendales
MD
J. Andres Hernandez
MD
MBA
and Emmanuel O. Emovon
III
BS ALLOGRAFT REJECTION 532 Acute T-Cell- and Antibody-Mediated Rejection A. Brad Farris
III
MD
MBA
Ivy A. Rosales
MD
and Robert B. Colvin
MD 540 Chronic Rejection A. Brad Farris
III
MD
MBA
Robert B. Colvin
MD
and Ivy A. Rosales
MD SECTION 11: POSTTRANSPLANT NEOPLASTIC DISORDERS 544 Posttransplant Lymphoproliferative Diseases A. Brad Farris
III
MD
MBA